Pharmacokinetic Characterization of the Active, Separated System With PK Controller (Fentanyl Iontophoretic Transdermal System, 40 Mcg Fentanyl Per Activation).
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2013
At a glance
- Drugs Fentanyl (Primary) ; Fentanyl (Primary) ; Naltrexone
- Indications Pain
- Focus Pharmacokinetics
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jan 2013 New trial record